Inhibrx Biosciences, Inc.
INBX
$12.48
$0.151.22%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -22.28% | -13.46% | -- | -- | -- |
| Total Receivables | -62.73% | -18.75% | 356.25% | -60.93% | -- |
| Inventory | -34.60% | -38.05% | -40.63% | -16.00% | -- |
| Prepaid Expenses | -17.79% | -25.08% | 70.35% | -29.68% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -34.89% | -11.62% | 31.52% | 44.70% | -- |
| Total Current Assets | -22.68% | -14.30% | 1,606.67% | -95.20% | -- |
|
|
|||||
| Total Current Assets | -22.68% | -14.30% | 1,606.67% | -95.20% | -- |
| Net Property, Plant & Equipment | 61.09% | -12.60% | 1.72% | 0.88% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.77% | -0.49% | 47.08% | 44.94% | -- |
| Total Assets | -18.78% | -13.88% | 815.66% | -90.83% | -- |
|
|
|||||
| Total Accounts Payable | 9.09% | -22.28% | 0.13% | -48.06% | -- |
| Total Accrued Expenses | -15.26% | 48.09% | 2.90% | -8.36% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -13.08% | -15.48% | 2.55% | 2.62% | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -7.63% | 12.91% | 1.62% | -31.75% | -- |
|
|
|||||
| Total Current Liabilities | -7.63% | 12.91% | 1.62% | -31.75% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -49.46% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.00% | 12.91% | 0.15% | -85.25% | -- |
|
|
|||||
| Common Stock & APIC | 1.26% | 1.27% | 2,270.56% | -101.64% | -- |
| Retained Earnings | -82.15% | -304.55% | -- | -- | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -25.15% | -18.64% | 2,136.82% | -124.76% | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -25.15% | -18.64% | 2,136.82% | -124.76% | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -25.15% | -18.64% | 2,136.82% | -124.76% | -- |
|
|
|||||